Adults suffering from acute ischemic stroke are advised to consider tenecteplase as a therapy option by the National Institute for Health and Care Excellence (NICE). This choice represents a major advancement in the treatment of strokes and may have a big effect on patient care and NHS budget. Boehringer Ingelheim’s Tenecteplase, also marketed under the...
An innovative project focused on creating cutting-edge precision medicine (PM) and artificial intelligence (AI) strategies for the treatment and management of multiple sclerosis (MS) has been generously funded with AU$2.9 million (roughly $1.96 million USD) by the Australian government’s Medical Research Future Fund (MRFF). With a multidisciplinary approach, this innovative study will be led by...